Clinical Trial Update: FAPi-PET Imaging of in Vivo Fibrosis in Inflammatory Bowel Disease Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating FAPi-PET imaging of in vivo fibrosis in inflammatory bowel disease patients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease
• Ulcerative Colitis

Drugs mentioned

• FAPi-PET imaging agent (Fibroblast Activation Protein imaging tracer)

Snippet

Sponsor: Dalia Lartey | Conditions: IBD (Inflammatory Bowel Disease), Crohn Disease (CD) | Phase 2 | Status: RECRUITING